STOCK TITAN

BullFrog AI CEO Vin Singh to Participate in Panel Discussion at Money Show in Las Vegas

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
conferences
Rhea-AI Summary

GAITHERSBURG, Md., April 13, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, a digital technology company focused on precision medicine, announced CEO Vin Singh's participation in a panel at the Money Show in Las Vegas on April 24-26, 2023. The panel, titled 'Innovators in a Dynamic Tech Environment - A Perfect Fit for Your Portfolio,' will occur at 3:10 p.m. PT on April 24 and 1:15 p.m. PT on April 25.

Singh plans to discuss the company's vision and how its machine learning technology enhances drug development. Following its recent Nasdaq IPO, BullFrog AI aims to accelerate progress in the coming quarters. The Money Show connects investors with financial experts, providing insights and strategies.

For more details, visit the company's website.

Positive
  • None.
Negative
  • None.

GAITHERSBURG, Md., April 13, 2023 (GLOBE NEWSWIRE) -- BullFrog AI Holdings, Inc. (Nasdaq: BFRG; BFRGW) ("Bullfrog AI" or the "Company"), a digital technology company using machine learning to usher in a new era of precision medicine, announced its Founder and CEO, Vin Singh, will participate in a panel discussion at the Money Show, taking place at the Paris Las Vegas Hotel & Casino April 24-26, 2023. 

Investors will have two opportunities to attend the panel discussion "Innovators in a Dynamic Tech Environment - A Perfect Fit for Your Portfolio," hosted Monday, April 24, at 3:10 p.m. PT and again on Tuesday, April 25, at 1:15 p.m. PT.

"I look forward to the opportunity to discuss BullFrog AI's vision for a new era of precision medicine and how we are using machine learning to transform the drug development process," said Singh. "Thanks to our recent Nasdaq IPO, we are now operating from a significantly stronger financial foundation that we believe will accelerate our progress and accomplishments in the quarters ahead. We are excited to share our progress and plans for the future with attendees at the show."

For 40 years, MoneyShow has maintained market dominance in connecting self-directed investors and active traders with world-class financial experts. The very basis for MoneyShow’s existence is to deliver to this targeted audience truly elite-caliber advice, actionable recommendations, new opportunities, and profitable strategies from a wide network of knowledgeable, experienced experts.

Register now to meet BullFrog AI's CEO in person.

About BullFrog AI

BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. Through its collaborations with leading research institutions, including Johns Hopkins University, BullFrog AI is at the forefront of AI-driven drug development. Using its proprietary bfLEAP™ artificial intelligence platform, BullFrog AI aims to enable the successful development of pharmaceuticals and biologics by predicting which patients will respond to therapies in development. BullFrog AI is deploying bfLEAP™ for use at several critical stages of development with the intention of streamlining data analytics in therapeutics development, decreasing the overall development costs by decreasing failure rates for new therapeutics, and impacting the lives of countless patients that may have otherwise not received the therapies they need.

For more information visit BullFrog AI at:
Website: www.bullfrogai.com
LinkedIn: https://www.linkedin.com/company/bullfrogai/

Forward-Looking Statements

This press release contains forward-looking statements. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

Contact:
Dave Gentry
RedChip Companies, Inc.
BFRG@redchip.com
800-733-2447

SOURCE: BullFrog AI Holdings, Inc.


FAQ

When will BullFrog AI's CEO participate in the Money Show?

Vin Singh will participate in the Money Show on April 24-26, 2023, with panel discussions on April 24 at 3:10 p.m. PT and April 25 at 1:15 p.m. PT.

What is the focus of BullFrog AI at the Money Show?

BullFrog AI will focus on its vision for precision medicine and the impact of machine learning on drug development.

What are the stock symbols for BullFrog AI?

The stock symbols for BullFrog AI are BFRG and BFRGW.

What significant event did BullFrog AI recently experience?

BullFrog AI recently completed its IPO on Nasdaq, strengthening its financial foundation.

How does BullFrog AI contribute to drug development?

BullFrog AI uses its bfLEAP™ platform to predict patient responses to therapies, streamlining the drug development process.

Bullfrog AI Holdings, Inc.

NASDAQ:BFRG

BFRG Rankings

BFRG Latest News

BFRG Stock Data

19.95M
8.71M
29.2%
3.48%
3.28%
Health Information Services
Pharmaceutical Preparations
Link
United States of America
GAITHERSBURG